Literature DB >> 31773005

Biological Model for Predicting Toxicity in Head and Neck Cancer Patients Receiving Proton Therapy.

Croix C Fossum1, Chris J Beltran2, Thomas J Whitaker2, Daniel J Ma2, Robert L Foote2.   

Abstract

PURPOSE: To use a linear energy transfer (LET) dependent formula for relative biological effectiveness (RBE) to generate a biological model that can be used to predict toxicity in patients treated with proton therapy for cancer of the head and neck. PATIENTS AND METHODS: Patients treated with protons to a dose of 60 to 70 Gy (RBE = 1.1) for head and neck cancer were eligible to participate in this study. Treatment plans were developed using graphics processing unit Monte Carlo calculations. The equation, RBE = (1.1)[0.08(LETd)+0.88], was the biological model. The physical model assumes RBE = 1.1. Tumor volumes and organs at risk (OARs) were contoured, and isodose lines were created for 105%-120% of the prescribed dose. Dose to volume of OARs was calculated for both models for comparative purposes. Physician-reported toxicity was graded from 0 to 5 using the Common Terminology Criteria for Adverse Events, version 4.03. Patient-reported outcomes were obtained using the Promis10 and European Organisation for Research and Treatment of Cancer's QLQ-H&N35 instruments.
RESULTS: Eleven patients were included in this study. In each case the biological model revealed an increased dose to several OARs compared with the physical model. For selected OARs, the volume receiving >105% of the target dose was 2-fold to 15-fold greater in the biological model than the volume predicted by the physical model. Patients experienced toxicity that was consistent with the dose to OARs predicted by the biological model. Furthermore, 1 patient developed mucosal ulceration and another developed osteoradionecrosis at the location of a biological hot spot. In each case, the biological hot spot was located 2 mm inside the clinical target volume.
CONCLUSION: The results suggest that increases in dose predicted by the biological model are clinically relevant and that LET and RBE corrections and optimization should be a component of the treatment-planning process in proton therapy. © Copyright 2017 International Journal of Particle Therapy.

Entities:  

Keywords:  head and neck cancer; organ at risk; osteoradionecrosis; proton therapy; relative biological effectiveness

Year:  2017        PMID: 31773005      PMCID: PMC6871554          DOI: 10.14338/IJPT-17-00015

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  13 in total

1.  Range uncertainty in proton therapy due to variable biological effectiveness.

Authors:  Alejandro Carabe; Maryam Moteabbed; Nicolas Depauw; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-02-14       Impact factor: 3.609

2.  Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.

Authors:  Terence T Sio; Huei-Kai Lin; Qiuling Shi; G Brandon Gunn; Charles S Cleeland; J Jack Lee; Mike Hernandez; Pierre Blanchard; Nikhil G Thaker; Jack Phan; David I Rosenthal; Adam S Garden; William H Morrison; C David Fuller; Tito R Mendoza; Radhe Mohan; Xin Shelley Wang; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-18       Impact factor: 7.038

Review 3.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

4.  A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.

Authors:  Minna Wedenberg; Bengt K Lind; Björn Hårdemark
Journal:  Acta Oncol       Date:  2012-08-22       Impact factor: 4.089

5.  Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.

Authors:  Hok Seum Wan Chan Tseung; Jiasen Ma; Cole R Kreofsky; Daniel J Ma; Chris Beltran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-06       Impact factor: 7.038

6.  Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.

Authors:  Jan Unkelbach; Pablo Botas; Drosoula Giantsoudi; Bram L Gorissen; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-01       Impact factor: 7.038

7.  Relative biological effectiveness (RBE) values for proton beam therapy.

Authors:  Harald Paganetti; Andrzej Niemierko; Marek Ancukiewicz; Leo E Gerweck; Michael Goitein; Jay S Loeffler; Herman D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

8.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

Authors:  Pierre Blanchard; Adam S Garden; G Brandon Gunn; David I Rosenthal; William H Morrison; Mike Hernandez; Joseph Crutison; Jack J Lee; Rong Ye; C David Fuller; Abdallah S R Mohamed; Kate A Hutcheson; Emma B Holliday; Nikhil G Thaker; Erich M Sturgis; Merrill S Kies; X Ronald Zhu; Radhe Mohan; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-06-21       Impact factor: 6.280

9.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

10.  Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.

Authors:  Mark W McDonald; Yuan Liu; Michael G Moore; Peter A S Johnstone
Journal:  Radiat Oncol       Date:  2016-02-27       Impact factor: 3.481

View more
  3 in total

1.  Biological Effectiveness of Ion Beam for In Vitro Cell Irradiations.

Authors:  Heng Li
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

Review 2.  Osteoradionecrosis of the jaw: A mini review.

Authors:  Annu Singh; Joseph M Huryn; Kenneth L Kronstadt; SaeHee K Yom; Joseph R Randazzo; Cherry L Estilo
Journal:  Front Oral Health       Date:  2022-07-28

3.  Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer.

Authors:  Nathan Y Yu; Aditya Khurana; Daniel J Ma; Michelle A Neben-Wittich; Michael A Golafshar; Lisa A McGee; Jean-Claude M Rwigema; Robert L Foote; Samir H Patel
Journal:  Int J Part Ther       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.